| Literature DB >> 35216284 |
Simonetta Pazzaglia1, Barbara Tanno1, Ilaria De Stefano1, Paola Giardullo1, Simona Leonardi1, Caterina Merla1, Gabriele Babini2, Seda Tuncay Cagatay3, Ammar Mayah3, Munira Kadhim3, Fiona M Lyng4, Christine von Toerne5, Zohaib N Khan5, Prabal Subedi5, Soile Tapio5, Anna Saran1, Mariateresa Mancuso1.
Abstract
Cell communication via exosomes is capable of influencing cell fate in stress situations such as exposure to ionizing radiation. In vitro and in vivo studies have shown that exosomes might play a role in out-of-target radiation effects by carrying molecular signaling mediators of radiation damage, as well as opposite protective functions resulting in resistance to radiotherapy. However, a global understanding of exosomes and their radiation-induced regulation, especially within the context of an intact mammalian organism, has been lacking. In this in vivo study, we demonstrate that, compared to sham-irradiated (SI) mice, a distinct pattern of proteins and miRNAs is found packaged into circulating plasma exosomes after whole-body and partial-body irradiation (WBI and PBI) with 2 Gy X-rays. A high number of deregulated proteins (59% of WBI and 67% of PBI) was found in the exosomes of irradiated mice. In total, 57 and 13 miRNAs were deregulated in WBI and PBI groups, respectively, suggesting that the miRNA cargo is influenced by the tissue volume exposed to radiation. In addition, five miRNAs (miR-99b-3p, miR-200a-3p, miR-200a, miR-182-5p, miR-182) were commonly overexpressed in the exosomes from the WBI and PBI groups. In this study, particular emphasis was also given to the determination of the in vivo effect of exosome transfer by intracranial injection in the highly radiosensitive neonatal cerebellum at postnatal day 3. In accordance with a major overall anti-apoptotic function of the commonly deregulated miRNAs, here, we report that exosomes from the plasma of irradiated mice, especially in the case of WBI, prevent radiation-induced apoptosis, thus holding promise for exosome-based future therapeutic applications against radiation injury.Entities:
Keywords: apoptosis; exosomes; ionizing radiation; miRNome; neonatal cerebellum; proteomics
Mesh:
Substances:
Year: 2022 PMID: 35216284 PMCID: PMC8878539 DOI: 10.3390/ijms23042169
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Experimental design scheme. Eight weeks old C57Bl/6 female mice were SI or subjected to WBI or PBI with 2.0 Gy of X-rays. PBI was performed by exposing the lower third of the mouse body, whilst the upper two-thirds were shielded with a lead shield. Twenty-four hours post-irradiation mouse blood was collected and plasma separated by centrifugation for exosome extraction. Exosomes were used for (i) NGS-based miRNome analysis, (ii) proteomic analysis, and (iii) in vivo functional testing.
Figure 2(A) Numbers of reads pre- and post-quality filtering and (B) characterization of mouse plasma exosomal small non-coding RNA content. The dataset for each treatment group—SI, WBI, and PBI—comprise three individual exosomal preparations from plasma pooled from 5 mice. The fraction of miRNAs is marked by an arrow.
Figure 3Volcano plots analysis. Fold-change and p-values of all differentially expressed miRNAs between 2 Gy-WBI-irradiated (A) and 2 Gy-PBI-irradiated (B) plasma exosomes vs. 0 Gy plasma exosomes. Fold-change (log2) versus significance (-log10 p-value) for each miRNA is shown. Significant miRNAs (FDR < 0.05) are in blue. (C) Venn diagram of the significantly deregulated miRNAs in the exosomes of PBI and WBI mice vs. SI mice, with shared miRNAs listed.
Figure 4Pathway analyses of plasma-derived exosomal miRNA. Histograms describing the most significant REACTOME pathways associated to the statistically significant miRNAs altered in 2 Gy-WBI (A) and in in 2 Gy-PBI (B) vs. SI plasma derived exosomes. All differentially expressed miRNAs are listed in Tables S1 and S2. The horizontal axis shows the percentage of pathway deregulation due to differentially expressed genes out of all genes included in each pathway term. At the end of each histogram, the number of differentially expressed genes in the pathway term is reported. Histograms of same color represent groups of terms with interrelations. Red asterisks refer to significance in the percentage of pathway deregulation (* p < 0.05).
Figure 5Proteomics analysis of the plasma exosomes 24 h after partial-body irradiation (2 Gy PBI) or whole-body irradiation (2 Gy WBI) compared to the sham-irradiated (SI) controls. (A) Supervised heat map showing the separation of PBI and WBI samples from controls based on the significantly differentially expressed proteins in each condition (q > 0.05, fold change > 1.30 or < 0.77, protein identification with at least two unique peptides). The heat map does not discriminate between the WBI and PBI samples. The red bars indicate upregulation and the green bars downregulation. (B) Venn diagram showing the number of total and shared significantly differentially regulated proteins using PBI (blue circle) and WBI (red circle) compared to the SI controls. (C) Protein interaction analysis showing all significantly differentially regulated proteins in the PBI group. Three clusters are shown: mitochondrial proteins (blue balls), ribosomal proteins (yellow balls), and proteins involved in blood coagulation (red balls). The analysis was performed using the STRING database [42].
Significantly differentially regulated proteins in mouse blood exosomes of PBI at 2 Gy.
| Accession | Description | Gene Symbol | Abundance Ratio |
|---|---|---|---|
| Q9D0M3 |
|
| 0.010 |
| O54990 |
|
| 0.010 |
| Q8JZM8 |
|
| 0.010 |
| Q62168 |
|
| 0.010 |
| Q497I4 |
|
| 0.010 |
| O70456 |
|
| 0.010 |
| P97350 | Plakophilin-1 |
| 0.010 |
| Q8BZ98 | Dynamin-3 |
| 0.010 |
| P70315 | Wiskott–Aldrich syndrome protein homolog |
| 0.010 |
| Q923U0 | TOM1-like protein 1 |
| 0.010 |
| P47963 | 60S ribosomal protein L13 |
| 0.010 |
| P12970 | 60S ribosomal protein L7a |
| 0.010 |
| P62281 | 40S ribosomal protein S11 |
| 0.010 |
| O09167 |
|
| 0.010 |
| P62717 |
|
| 0.010 |
| Q8VCM7 |
|
| 0.031 |
| Q8K0E8 | Fibrinogen beta chain |
| 0.038 |
| E9PV24 |
|
| 0.040 |
| Q9D3D9 | ATP synthase subunit delta, mitochondrial |
| 0.040 |
| Q7TMD7 |
|
| 0.094 |
| Q99K41 | EMILIN-1 |
| 0.096 |
| P97861 |
|
| 0.106 |
| Q60841 |
|
| 0.139 |
| Q9JHJ0 |
|
| 0.143 |
| Q3SXB8 | Collectin-11 |
| 0.143 |
| Q8BH61 |
|
| 0.151 |
| Q8R0Z6 | Angiopoietin-related protein 6 |
| 0.154 |
| P15864 |
|
| 0.168 |
| Q9JLY7 |
|
| 0.180 |
| Q63836 | Selenium-binding protein 2 |
| 0.184 |
| Q8CF98 | Collectin-10 |
| 0.184 |
| P62806 | Histone H4 |
| 0.187 |
| Q9D1R9 | 60S ribosomal protein L34 |
| 0.189 |
| P84099 | 60S ribosomal protein L19 |
| 0.201 |
| Q07968 | Coagulation factor XIII B chain |
| 0.204 |
| Q6ZWV3 | 60S ribosomal protein L10 |
| 0.210 |
| P62267 | 40S ribosomal protein S23 |
| 0.244 |
| P17710 | Hexokinase-1 |
| 5.598 |
| P19783 |
|
| 6.534 |
| Q64521 |
|
| 6.570 |
| Q64314 |
|
| 8.780 |
| Q9Z126 | Platelet factor 4 |
| 14.195 |
| Q9DCW4 |
|
| 100.00 |
| Q8K021 |
|
| 100.00 |
| Q4FJU9 |
|
| 100.00 |
| P70168 |
|
| 100.00 |
| Q61559 |
|
| 100.00 |
| Q8VEK3 |
|
| 100.00 |
| B2RUP2 |
|
| 100.00 |
| Q7TQ48 |
|
| 100.00 |
| P51660 |
|
| 100.00 |
| P53994 |
|
| 100.00 |
| Q91VD9 |
|
| 100.00 |
| Q8BMS1 |
|
| 100.00 |
| P06880 |
|
| 100.00 |
| Q6Q477 |
|
| 100.00 |
| O35639 |
|
| 100.00 |
| Q3TL44 |
|
| 100.00 |
| Q9JIM1 |
|
| 100.00 |
| P35486 |
|
| 100.00 |
| O08795 |
|
| 100.00 |
| Q9ET30 |
|
| 100.00 |
| Q8K2B3 |
|
| 100.00 |
| P50096 |
|
| 100.00 |
| Q99KI0 |
|
| 100.00 |
| P97429 |
|
| 100.00 |
| Q9Z1G4 |
|
| 100.00 |
| Q08481 |
|
| 100.00 |
| Q3V0K9 |
|
| 100.00 |
| E9PYK3 |
|
| 100.00 |
| Q9CR68 |
|
| 100.00 |
| P61804 |
|
| 100.00 |
| P05366 |
|
| 100.00 |
| Q60864 | Stress-induced-phosphoprotein 1 |
| 100.00 |
| Q8K4F0 | CD226 antigen |
| 100.00 |
1 Protein accession number, description, gene symbol, and abundance ratio (fold change) are shown. The deregulated proteins shared between PBI and WBI are shown in bold. Abundance ratios of 100.00 indicate that the protein is only found in the irradiated sample.
Figure 6Evaluation of cleaved-caspase-3 response after exosome intracranial injection in unirradiated neonatal mice at P3. (A) Experimental design scheme. (B) Intracranial injection of exosomes with a Hamilton microsyringe. (C) Assessment of injection site after microscopic morphological examination. (D,E) Lane 1: size marker; lane 2: sham-injected cerebellum (PBS); lane 3: cerebellum injected with 0 Gy-plasma-derived exosomes (EXO 0 Gy); lane 4: cerebellum injected with 2 Gy-PBI-plasma-derived exosomes (EXO PBI); lane5: cerebellum injected with 2 Gy-WBI-plasma-derived exosomes (EXO WBI). Band intensities of cleaved-caspase-3 were sampled three times and normalized for β-actin. (F) Densitometric analysis of activated caspase-3 in cerebella injected with plasma exosomes derived at 24 h post-irradiation. (G) Densitometric analysis of activated caspase-3 in cerebella injected with plasma Evs derived at 1 h post-irradiation. * p < 0.05. ** p ≤ 0.01
Figure 7Evaluation of cleaved-caspase-3 response after exosome injection in WBI neonatal mice at P3. (A) Lane 1: size marker; lane 2: cerebellum injected with 0 Gy-plasma-derived exosomes (EXO 0 Gy); lane 3: cerebellum injected with 2 Gy-PBI-plasma-derived exosomes (EXO PBI); lane4: cerebellum injected with 2 Gy-WBI-plasma-derived exosomes (EXO WBI), lane 5: cerebellum from 2 Gy whole body irradiated P2 mice. Band intensities of cleaved caspase-3 were sampled three times and normalized for β- actin. (B) Densitometric analysis of activated caspase-3 in cerebella irradiated with 2 Gy of X-rays and then injected with plasma exosomes derived at 24 h post-irradiation. * p < 0.05.